Several drugs have been developed with the ability to restore a wild-type-like structure of p53 mutants, the ability to induce the transcription of p53-dependent genes and to promote antitumor activity, inhibiting cell proliferation and tumor growth [260]. This evidence concerns the gene TP53 and neoplasm.